Companies/Lipum AB
Follow

Lipum AB

Nasdaq First North GM Stockholm (Sweden)

Lipum is a biopharmaceutical company. It specializes in the discovery and development of new treatment for chronic inflammatory diseases. The drug candidate SOL-116 is a humanized antibody that aims to provide safer and more effective treatment by blocking a previously overlooked target molecule (BSSL) in the immune system.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 4
View all
www.lipum.se
Current instruments
Type
Ticker
ISIN
SHARE
LIPUM
SE0015660899
Nasdaq First North GM Stockholm Sweden (SE)
OPTION
LIPUM TO1
SE0015810429
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
LIPUM
SE0015660899
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Lipum AB with ticker LIPUM
Status
Active
Amount of instruments
5 052 492
Currency
SEK
First trading date
22 Apr 2021
Type
Ticker
ISIN
Market
OPTION
LIPUM TO1
SE0015810429
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Lipum AB with ticker LIPUM TO1
Status
Active
Amount of instruments
2 695 000
Currency
SEK
Trading period
22 Apr 2021 - 29 Aug 2022
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share for SEK 45.0 during the subscription period from August 1, 2022 - August 31, 2022.
Exercise
Sign in to buy
People
Einar Pontén
CEO
Ulf Björklun
Chairman of the board
Olle Hernell
Board member
Lennart Lundberg
Board member
Kristian Sandberg
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Tvistevägen 48 C
Zip code
907 36
City/district
Umeå
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556813-5999
LEI code
549300V7JL0004BHBD93
First trade date
22 Apr 2021
Registration date
02 Jul 2010
Short name
Lipum

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More